Who We Are

CNSintel provides a high quality confidential assessment of the research plans of our clients from academic experts in the field.

Guided by a small panel of London-based academics, with extensive experience of a broad range of neuroscience and no ties to pharmaceutical companies, we invite a group of internationally-recognized neuroscientists, selected for their relevant expertise, to review the research plans of our clients.

CNSintel was founded by Dr Narges Bazargani, a PhD graduate of University College London’s prestigious 4 year PhD Programme in Neuroscience, who has experience in drug development at both start-up and large long-established pharmaceutical companies.

CNSintel believes that catalysing the confidential exchange and assessment of novel scientific ideas on neuroscience drug-development projects will lead to innovative solutions for therapy.